《2023年欧洲肿瘤内科学会临床实践指南:胰腺癌的诊断、治疗和随访》意见要点
DOI: 10.3969/j.issn.1001-5256.2023.12.009
利益冲突声明:本文不存在任何利益冲突。
作者贡献声明:陈哲然负责文章翻译;辛磊与王洛伟负责文章审校。
Key points in pancreatic cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up (2023)
-
摘要: 2023年9月欧洲肿瘤内科学会在AmalsofOncology上发表了“2023年欧洲肿瘤内科学会临床实践指南:胰腺癌的诊断、治疗和随访”。该指南围绕胰腺癌(PC)的流行病学、诊断和治疗等方面提出建议。该指南指出了PC的高危人群与建议筛查方法,明确了PC的诊断流程和各种影像学、分子生物学检查手段,提出了各型PC适宜的治疗方法。本文对该指南进行摘译,介绍了指导意见中PC临床诊疗的相关指导,以期为临床实践提供参考依据。Abstract: In September 2023, the European Society for Medical Oncology published Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up in Annals of Oncology. The guideline provides recommendations on the epidemiology, diagnosis, and treatment of pancreatic cancer (PC). The guideline highlights the high-risk populations of PC and recommended screening methods, clarifies the diagnostic process of PC and various radiological and molecular biology tests, and mentions the appropriate treatment methods for different types of PC. This article makes an excerpt of this guideline and introduces related recommendations for the clinical treatment of PC, in order to provide a reference for clinical practice.
-
Key words:
- Pancreatic Neoplasms /
- Diagnosis /
- Therapeutics /
- Practice Guideline /
- Europe
-
-
[1] CONROY T, PFEIFFER P, VILGRAIN V, et al. Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up[J]. Ann Oncol, 2023. DOI: 10.1016/j.annonc.2023.08.009.[ Online ahead of print]